Assyro AI

Orange Book product · Brand (NDA)

INTRAROSA

PRASTERONE

Brand (NDA)NDA 208470RX MILLICENT

At a glance

Nov 16, 2016

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 16, 2016

    9 yr 9 mo ago

  2. Today

  3. Patent 8629129 expires

    Listed drug product patent expiration.

    Aug 07, 2028

    in 2 yr 2 mo

  4. Patent 8957054 expires

    Listed method-of-use patent (U-1922) expiration.

    Jan 08, 2030

    in 3 yr 7 mo

  5. Patent 8268806 expires

    Listed drug product patent expiration.

    Mar 19, 2031

    in 4 yr 10 mo

Pharmaceutical detail

Active ingredient

PRASTERONE

Strength

6.5MG

Dosage form

INSERT

Route

VAGINAL

TE code

Not listed

Application

NDA 208470

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8629129Aug 07, 2028in 2 yr 2 mo
Product
8957054Jan 08, 2030in 3 yr 7 mo
U-1922
8268806Mar 19, 2031in 4 yr 10 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.